Trial Profile
Romosozumab and Teriparatide Effects on Lumbar Spine and Hip Volumetric Bone Mineral Density and Content.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2022
Price :
$35
*
At a glance
- Drugs Romosozumab (Primary) ; Teriparatide
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Amgen
- 01 Feb 2022 Data from this study was analyzed for lumbar computed tomography (CT) spine scans at enrollment and 12 months post-treatment with romosozumab, published in the Journal of Bone and Mineral Research.
- 08 Dec 2014 New trial record